TP53 and cancer: Therefore, we made a further analysis of TP53. It was observed that TP53 was more frequently disrupted by nonsense mutations, frame‐shift indels and splice site mutations compared with other cRMGs (Figure 3a), which results in the initiation and progression of cancers (Payne & Kemp, 2005; Wojnarowicz et al., 2012).